Novavax's total assets for Q3 2025 were $1.18B, a decrease of -11.72% from the previous quarter. NVAX total liabilities were $1.34B for the fiscal quarter, a 2.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.